Trials / Completed
CompletedNCT01773967
Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 971 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 3 Months – 48 Months
- Healthy volunteers
- Not accepted
Summary
The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.
Detailed description
Multicenter randomized controlled trial of LGG in patients 3-48 months of age presenting to the Emergency Department with acute gastroenteritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LGG | LGG 10\^10 cfu PO BID X 5 days |
| DRUG | micro-crystalline cellulose | 1 capsule PO bid x 5 days |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2013-01-23
- Last updated
- 2019-09-06
- Results posted
- 2019-09-06
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01773967. Inclusion in this directory is not an endorsement.